News|Articles|August 17, 2011

Equipment and Processing Report

  • Equipment and Processing Report-08-17-2011
  • Volume 0
  • Issue 0

Finding the End of the Granulation Process

We try to use previous experience to develop the optimal granulation process for each new ingredient, but we sometimes get it wrong. Many times, we?ve taken materials from the granulator only to find that they exhibit poor flow and insufficient density. How can we easily determine the end point of a given granulation process?

Q: Our facility manufactures several products, and, from time to time, we must process ingredients that we haven’t encountered before through wet granulation. We try to use previous experience to develop the optimal granulation process for each new ingredient, but we sometimes get it wrong. Many times, we’ve taken materials from the granulator only to find that they exhibit poor flow and insufficient density. How can we easily determine the end point of a given granulation process?

A: One solution is to track wet granulation using a powder rheometer. Powder rheometers characterize samples by measuring them in motion. Basic flow energy (BFE), a dynamic powder parameter, can be a sensitive marker of the transition point from wet mass to granules and a precise tool for detecting when granules have attained their optimal properties.

BFE is the energy required to induce a specific flow pattern in a conditioned powder bed. One can measure BFE with a powder rheometer easily using wet samples taken directly from the granulator. Pause the granulation, extract a representative sample for measurement directly into the flow vessel of the powder rheometer, and continue processing if necessary.

To ensure a homogenous, representative sample, avoid the areas around the spray nozzle and walls, where material tends to be less uniform. Use large sample sizes for large granulates to ensure representative sampling of the batch. Automated measurement protocols can make the measurement fast and highly reproducible. The axial and rotational forces acting on a helical blade as it rotates through the sample are precisely measured to quantify the resistance of the bed (through BFE), which is governed by the properties of the wet granulate.

As water content increases, BFE climbs slowly, and it rises sharply at concentrations coincident with the end point. Physical examination of the samples suggests that this sharp rise corresponds with the transition from wet mass to granules.

Because BFE is independent of scale, it is of great value when switching from laboratory to pilot to commercial scale. Processing to an endpoint defined in this way gives the operator scope to vary conditions in response to changing feed, scale, or equipment. The approach also is consistent with quality by design.

—Tim Freeman, director of operations for Freeman Technology

 

If you have a problem with your equipment or process, an industry expert may have the solution. Please send your question to Erik Greb, editor of Equipment and Processing Report, and we may be able to provide an answer in a future issue. All questions will remain anonymous.

Articles in this issue


Related to this article

Glass vial, pipette and woman scientist in laboratory for medical study, research or experiment. Test tube, dropper and professional female person with chemical liquid for pharmaceutical innovation. | Image Credit: ©HockleyMedia24/peopleimages.com -stock.adobe.com
Equivalence test using two one-sided tests are widely used for demonstrating the comparability of treatment effects in different research fields. The method described in the manuscript aims to use simulations in Microsoft Excel to compute power for 2 one-sided tests for two groups with unequal variances.
CPHI Milan 2026: Nitrosamine Risk Mitigation, Part 2
Mitigating nitrosamine risk requires assessing each product individually, says Bram Baert, Global Head of Regulatory Affairs at Capsugel, and Sandrine Picco, Senior Analytical Specialist on Capsugel's Innovaform Accelerator Team, in this interview with PharmTech.
PharmTech Weekly Roundup—October 2, 2026
This week on PharmTech, Merck diversified its pipeline, USP emphasizes supply chain security, AI systems are examined, and speakers preview their presentations at CPHI Milan and AAPS PharmSci 360.